- RecruitingNot Applicable
Can we identify young people and adults who may benefit from methylphenidate, the most common medication for ADHD, from their initial response to a single test dose rather than after several weeks of daily treatment?
Finding the right ADHD medication can take months of trial and error. This UK study looks at whether a single test dose of methylphenidate can show if it will work long-term. It aims to help people aged 12 to 64 get the right treatment much faster.
For: Attention-deficit/hyperactivity disorder (ADHD)United Kingdom · England - CompletedNot Applicable
MePFAC - A Drug Trial for the treatment of cancer-related Fatigue
Extreme tiredness is a common symptom for people with advanced cancer. The MePFAC study looks at whether a tablet called methylphenidate can help ease cancer-related fatigue. Researchers want to see if this daily medication improves energy and everyday quality of life better than a dummy pill.
For: Psychosocial Oncology and SurvivorshipUnited Kingdom · England - RecruitingNA
rTMS for Apathy Clinical Trial
This study looks at a brain stimulation treatment called rTMS for people with memory problems and a lack of interest, known as apathy. It aims to see if rTMS can help improve apathy, especially for those already taking medication or not.
For: Alzheimer Disease · Apathy in Dementia · DementiaCanada - Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
This study looks at how medicines mothers take get into breast milk and affect their babies. We need breastfeeding mums taking common drugs to help us learn more about drug levels in milk and babies, to ensure safer choices for mums and their infants.
For: Lactating Women on Select DOI · Breastfed Infants of Mothers on Select DOIUnited States · Canada